PL140573B1
(en)
*
|
1982-12-21 |
1987-05-30 |
Pfizer |
Method of obtaining new dihydropyridine derivatives
|
GB8306666D0
(en)
*
|
1983-03-10 |
1983-04-13 |
Pfizer Ltd |
Therapeutic agents
|
EP0125803A3
(en)
*
|
1983-04-27 |
1987-01-21 |
FISONS plc |
Pharmaceutically active dihydropyridines
|
EP0168841B1
(en)
*
|
1983-12-19 |
1988-09-28 |
Pfizer Limited |
Dihydropyridine intermediate
|
JPS60156671A
(ja)
*
|
1984-01-25 |
1985-08-16 |
Yamanouchi Pharmaceut Co Ltd |
ジヒドロピリジン誘導体およびその製造法
|
GB8414518D0
(en)
*
|
1984-06-07 |
1984-07-11 |
Pfizer Ltd |
Therapeutic agents
|
GR851819B
(pt)
*
|
1984-08-17 |
1985-11-26 |
Wyeth John & Brother Ltd |
|
GB8421039D0
(en)
*
|
1984-08-17 |
1984-09-19 |
Wyeth John & Brother Ltd |
Heterocyclic compounds
|
IL77843A
(en)
*
|
1985-02-11 |
1989-07-31 |
Syntex Inc |
Dihydropyridine derivatives,process and novel intermediates for their preparation and pharmaceutical compositions containing them
|
IL78642A0
(en)
*
|
1985-05-03 |
1986-08-31 |
Pfizer |
Dihydropyridines and pharmaceutical compositions containing them
|
DE3531498A1
(de)
*
|
1985-09-04 |
1987-03-05 |
Bayer Ag |
Dihydropyridin-2-hydroxyamine, verfahren zur herstellung und ihre verwendung in arzneimitteln
|
EP0225175A3
(en)
*
|
1985-11-28 |
1988-12-28 |
FISONS plc |
Dihydropyridine derivatives, processes for their preparation and pharmaceutical compositions thereof
|
DE3544211A1
(de)
*
|
1985-12-13 |
1987-06-19 |
Bayer Ag |
Neue, fluorhaltige 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
|
IT1204460B
(it)
*
|
1986-02-20 |
1989-03-01 |
Glaxo Spa |
Derivati eterociclici
|
GB8608335D0
(en)
*
|
1986-04-04 |
1986-05-08 |
Pfizer Ltd |
Pharmaceutically acceptable salts
|
FR2649395B1
(fr)
*
|
1989-07-04 |
1992-11-06 |
Adir |
Nouveau derive de la dihydro-1,4 pyridine denomme (-) i1(((amino-2 ethoxy)-2 ethoxy) methyli1) -2 (dichloro-2,3 phenyl)-4 ethoxycarbonyl-3 methoxycarbonyl-5 methyl-6 dihydro-1,4 pyridine, son procede de preparation et les compositions qui le contiennent
|
US4983740A
(en)
*
|
1986-08-04 |
1991-01-08 |
Adir Et Compagnie |
Process for 1,4-dihydropyridine compounds
|
FR2602231B1
(fr)
*
|
1986-08-04 |
1988-10-28 |
Adir |
Nouveaux derives de la dihydro-1,4 pyridine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
|
US5196410A
(en)
*
|
1986-10-31 |
1993-03-23 |
Pfizer Inc. |
Transdermal flux enhancing compositions
|
IT1213555B
(it)
*
|
1986-12-11 |
1989-12-20 |
Boehringer Biochemia Srl |
2 metiltiometildiidropiridine, un processo per laloro preparazione e composizioni farmaceutiche che le contengono.
|
JPS63196564A
(ja)
*
|
1987-02-10 |
1988-08-15 |
Agency Of Ind Science & Technol |
イミドオリゴマ−の製造方法
|
IT1215381B
(it)
*
|
1987-03-12 |
1990-02-08 |
Boehringer Biochemia Srl |
Farmaceutiche che le contengono. carbonil- e solfonil- derivati di 2-(aminoalchiltio)metil-1,4-diidropiridine, un metodo per la loro preparazione e composizioni
|
GB8709447D0
(en)
*
|
1987-04-21 |
1987-05-28 |
Pfizer Ltd |
Dihydropyridines
|
GB8710493D0
(en)
*
|
1987-05-02 |
1987-06-03 |
Pfizer Ltd |
Dihydropyridines
|
DE3906406C1
(pt)
*
|
1989-03-01 |
1990-10-25 |
Goedecke Ag, 1000 Berlin, De |
|
US5234943A
(en)
*
|
1989-04-13 |
1993-08-10 |
Bayer Aktiengesellschaft |
Fungicidal 3-(2-chloro-3-trifluoromethylphenyl)-4-cyanopyrrole
|
DE4128132A1
(de)
*
|
1991-08-24 |
1993-02-25 |
Bayer Ag |
3-(2-chlor-3-trifluormethylphenyl)-4-cyanopyrrol, dessen herstellung und verwendung und neue zwischenprodukte
|
FR2652083B1
(fr)
*
|
1989-09-20 |
1992-01-24 |
Ador Cie |
Nouveau procede de separation d'isomeres optiques des derives de la dihydro-1,4 pyridine.
|
US5270323A
(en)
*
|
1990-05-31 |
1993-12-14 |
Pfizer Inc. |
Method of treating impotence
|
CA2124445A1
(en)
*
|
1991-11-26 |
1993-06-10 |
James W. Young |
Methods and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine
|
US6057344A
(en)
|
1991-11-26 |
2000-05-02 |
Sepracor, Inc. |
Methods for treating hypertension, and angina using optically pure (-) amlodipine
|
US6162802A
(en)
*
|
1992-03-10 |
2000-12-19 |
Papa; Joseph |
Synergistic combination therapy using benazepril and amlodipine for the treatment of cardiovascular disorders and compositions therefor
|
EP1614420A3
(en)
*
|
1992-11-25 |
2006-04-19 |
Sepracor Inc. |
Treatment of hypertension, angina and other disorders using (-) amlodipine
|
US5389654A
(en)
*
|
1992-11-26 |
1995-02-14 |
Lek, Tovarna, Farmacevtskih In Kemicnih . . . |
3-ethyl 5-methyl(±)2-[2-(N-tritylamino)ethoxymethyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-6-methyl-3,5-pyridinedicarboxylate
|
SI9200344B
(sl)
*
|
1992-11-26 |
1998-06-30 |
Lek, |
Postopek za pripravo amlodipin benzensulfonata
|
US6221335B1
(en)
*
|
1994-03-25 |
2001-04-24 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
PT804229E
(pt)
|
1995-03-16 |
2003-06-30 |
Pfizer |
Utilizacao de amlodipina de um dos seus sais ou defelodipina em combinacao com um inibidor da en zima de conversao da angiotensina (ace) para no fabrico de um medicamento destinado ao tratamento da insuficiencia cardiaca congestiva nao isquemica
|
NZ280378A
(en)
*
|
1995-11-01 |
1998-04-27 |
Apotex Inc |
4-phenyl-1,4-dihydropyridine-3,5-dicarboxylic acid compounds, preparation, intermediate compounds
|
HU221810B1
(hu)
*
|
1997-08-12 |
2003-01-28 |
EGIS Gyógyszergyár Rt. |
Eljárás amlodipin-bezilát előállítására és az eljárás intermedierjei
|
GT199800127A
(es)
|
1997-08-29 |
2000-02-01 |
|
Combinaciones terapeuticas.
|
ZA9810320B
(en)
*
|
1997-11-14 |
2000-05-11 |
Gea Farmaceutisk Fabrik As |
Process for the preparation of 1,4-dihydropyridines and novel compounds of use for such purpose.
|
ZA9810319B
(en)
*
|
1997-11-14 |
2000-05-11 |
Gea Farmaceutisk Fabrik As |
Process for the preparation of acetal derivatives of 1,4-dihydropyridines, novel acetal derivatives and the use of the acetal derivatives for the preparation of other 1,4-dihydropyridines.
|
ES2151850B1
(es)
*
|
1998-10-26 |
2001-08-16 |
Esteve Quimica Sa |
Intermedio para la sintesis de amlodipino para su obtencion y utilizacion correspondiente.
|
HN2000000050A
(es)
|
1999-05-27 |
2001-02-02 |
Pfizer Prod Inc |
Sal mutua de amlodipino y atorvastatina
|
DK1180102T3
(da)
|
1999-05-27 |
2004-09-06 |
Pfizer Prod Inc |
Gensidige prodrugs af amlodipin og atorvastatin
|
UA72768C2
(en)
|
1999-07-05 |
2005-04-15 |
Richter Gedeon Vegyeszet |
A method for obtaining amilodipine benzenesulphonate
|
CN1091441C
(zh)
*
|
1999-12-04 |
2002-09-25 |
昆明赛诺制药有限公司 |
甲磺酸氨氯地平及其制法和应用
|
US6521647B2
(en)
|
2000-04-04 |
2003-02-18 |
Pfizer Inc. |
Treatment of renal disorders
|
HUP0300444A3
(en)
*
|
2000-04-11 |
2007-09-28 |
Sankyo Co |
Stabilized pharmaceutical compositions containing calcium channel blockers
|
WO2002017913A1
(fr)
*
|
2000-08-30 |
2002-03-07 |
Sankyo Company, Limited |
Compositions medicinales utilisees dans la prevention ou le traitement de l'insuffisance cardiaque
|
GB0027410D0
(en)
*
|
2000-11-09 |
2000-12-27 |
Pfizer Ltd |
Mutual prodrug of amlodipine and atorvastatin
|
US6737430B2
(en)
|
2000-11-09 |
2004-05-18 |
Pfizer, Inc. |
Mutual prodrug of amlodipine and atorvastatin
|
AT5874U1
(de)
|
2000-12-29 |
2003-01-27 |
Bioorg Bv |
Pharmazeutische zubereitungen enthaltend amlodipinmaleat
|
US7335380B2
(en)
|
2000-12-29 |
2008-02-26 |
Synthon Ip Inc. |
Amlodipine free base
|
CA2433191A1
(en)
*
|
2000-12-29 |
2002-07-11 |
Pfizer Limited |
Aspartate derivative of amlodipine as calcium channel antagonist
|
CA2433190C
(en)
|
2000-12-29 |
2005-11-15 |
Pfizer Limited |
Amlodipine hemimaleate
|
US6653481B2
(en)
*
|
2000-12-29 |
2003-11-25 |
Synthon Bv |
Process for making amlodipine
|
GB2371862B
(en)
|
2000-12-29 |
2004-07-14 |
Bioorg Bv |
Reference standards for determining the purity or stability of amlodipine maleate and processes therefor
|
MXPA03005882A
(es)
|
2000-12-29 |
2005-04-19 |
Pfizer Ltd |
Derivado amida de amlodipina.
|
CA2433193C
(en)
|
2000-12-29 |
2006-01-31 |
Pfizer Limited |
Amide derivative of amlodipine
|
AP2003002820A0
(en)
*
|
2000-12-29 |
2003-06-30 |
Pfizer Ltd |
"Process for making amlodipine maleate"
|
WO2002053538A1
(en)
*
|
2000-12-29 |
2002-07-11 |
Pfizer Limited |
Amlodipine fumarate
|
EP1345901A2
(en)
*
|
2000-12-29 |
2003-09-24 |
Bioorganics B.V. |
Process for making amlodipine, derivatives thereof, and precursors therefor
|
KR20030066782A
(ko)
*
|
2000-12-29 |
2003-08-09 |
화이자 리미티드 |
암로디핀 말레에이트를 제조하는 방법
|
KR100374767B1
(ko)
*
|
2001-03-13 |
2003-03-03 |
한미약품공업 주식회사 |
개선된 암로디핀의 제조 방법
|
KR100452491B1
(ko)
*
|
2001-03-29 |
2004-10-12 |
한미약품 주식회사 |
신규한 결정형 암로디핀 캠실레이트 염 및 그의 제조방법
|
EP1435954B1
(en)
*
|
2001-07-06 |
2010-01-13 |
LEK Pharmaceuticals D.D. |
A PROCESS FOR THE PREPARATION OF HIGHlLY PUREAMLODIPINE BENZENESULFONATE
|
US6680334B2
(en)
|
2001-08-28 |
2004-01-20 |
Pfizer Inc |
Crystalline material
|
GB0120808D0
(en)
*
|
2001-08-28 |
2001-10-17 |
Pfizer Ltd |
Crystalline material
|
US20030180354A1
(en)
*
|
2001-10-17 |
2003-09-25 |
Dr. Reddy's Laboratories Limited |
Amlodipine maleate formulations
|
US20040001886A1
(en)
*
|
2001-10-17 |
2004-01-01 |
Dr. Reddy's Laboratories Limited |
Stabilized pharmaceutical formulations containing amlodipine maleate
|
EP2266590A3
(en)
|
2002-02-22 |
2011-04-20 |
Shire LLC |
Active agent delivery sytems and methods for protecting and administering active agents
|
US6562983B1
(en)
*
|
2002-03-18 |
2003-05-13 |
Council Of Scientific And Industrial Research |
Process for the preparation of alkyl 4[2-(phthalimido)ethoxy]-acetoacetate
|
WO2003089414A1
(en)
*
|
2002-04-13 |
2003-10-30 |
Hanlim Pharmaceutical Co., Ltd. |
Amlodipine nicotinate and process for the preparation thereof
|
US6699892B2
(en)
|
2002-06-04 |
2004-03-02 |
Yung Shin Pharmaceutical Industrial Co., Ltd. |
Pharmaceutically acceptable salt of amlodipine and method of preparing the same
|
KR100496436B1
(ko)
*
|
2002-07-30 |
2005-06-20 |
씨제이 주식회사 |
암로디핀의 유기산염
|
KR20040011751A
(ko)
*
|
2002-07-30 |
2004-02-11 |
씨제이 주식회사 |
암로디핀의 유기산염
|
KR100462304B1
(ko)
|
2002-07-30 |
2004-12-17 |
씨제이 주식회사 |
암로디핀의 유기산염
|
KR100538641B1
(ko)
*
|
2002-07-30 |
2005-12-22 |
씨제이 주식회사 |
암로디핀의 유기산염
|
AU2003250483A1
(en)
|
2002-08-19 |
2004-03-11 |
Pfizer Products Inc. |
Combination therapy for hyperproliferative diseases
|
KR100467669B1
(ko)
*
|
2002-08-21 |
2005-01-24 |
씨제이 주식회사 |
암로디핀의 유기산염
|
US6784297B2
(en)
*
|
2002-09-04 |
2004-08-31 |
Kopran Limited |
Process for the preparation of anti-ischemic and anti-hypertensive drug amlodipine besylate
|
JP4319148B2
(ja)
|
2002-09-11 |
2009-08-26 |
ハンリム ファーマシューティカル カンパニー リミテッド |
S−(−)−アムロジピンニコチネート及びその製造方法
|
WO2004026834A1
(en)
*
|
2002-09-19 |
2004-04-01 |
Cj Corporation |
Crystalline organic acid salt of amlodipine
|
KR100596369B1
(ko)
|
2002-09-19 |
2006-07-03 |
씨제이 주식회사 |
결정형의 암로디핀 유기산염
|
US20040072879A1
(en)
*
|
2002-10-10 |
2004-04-15 |
Dr. Reddy's Laboratories Limited |
Crystalline 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine maleate salt (Amlodipine)
|
WO2004058711A1
(en)
*
|
2002-12-30 |
2004-07-15 |
Eos Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ticaret A.S. |
Isolation of dihydropyridine derivative and preparation salts thereof
|
DE10335027A1
(de)
*
|
2003-07-31 |
2005-02-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verwendung von Angiotensin II Rezeptor Antagonisten
|
NZ541454A
(en)
*
|
2003-01-31 |
2008-04-30 |
Daiichi Sankyo Co Ltd |
Medicine for prevention of and treatment for arteriosclerosis and hypertension
|
CA2559670A1
(en)
*
|
2003-04-14 |
2004-10-28 |
Gabor Pragai |
Stable amlodipine maleate formulations
|
US20050159403A1
(en)
*
|
2003-04-22 |
2005-07-21 |
Pharmacia Corporation |
Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of central nervous system damage
|
US20060135506A1
(en)
*
|
2003-04-22 |
2006-06-22 |
Pharmacia Corporation |
Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of pain, inflammation or inflammation mediated disorders
|
DE112004000712T5
(de)
*
|
2003-04-25 |
2006-10-19 |
Cipla Ltd. |
Verfahren zur Herstellung von Amlodipinmesilat-Monohydrat
|
WO2004110357A2
(en)
*
|
2003-05-16 |
2004-12-23 |
Ambit Biosciences Corporation |
Heterocyclic compounds and uses thereof
|
US20050182125A1
(en)
*
|
2003-05-16 |
2005-08-18 |
Ambit Biosciences Corporation |
Pyrrole compounds and uses thereof
|
AU2004242777B2
(en)
*
|
2003-05-30 |
2011-05-12 |
Ranbaxy Laboratories Limited |
Substituted pyrrole derivatives and their use as HMG-Co inhibitors
|
GB2419529B
(en)
*
|
2003-07-17 |
2008-01-09 |
Cotherix Inc |
Combination therapies for treatment of hypertension and complications in patients with diabetes or metabolic syndrome
|
US20050037063A1
(en)
*
|
2003-07-21 |
2005-02-17 |
Bolton Anthony E. |
Combined therapies
|
CH697952B1
(de)
*
|
2003-07-25 |
2009-03-31 |
Siegfried Generics Int Ag |
Verfahren zur Reinigung der freien Amlodipinbase.
|
WO2005023769A1
(en)
*
|
2003-09-04 |
2005-03-17 |
Cipla Limited |
Process for the preparation of amlodipine salts
|
TW200519091A
(en)
*
|
2003-09-10 |
2005-06-16 |
Synta Pharmaceuticals Corp |
Dihydropyridine compounds for treating or preventing metabolic disorders
|
KR100841409B1
(ko)
|
2003-12-16 |
2008-06-25 |
에스케이케미칼주식회사 |
암로디핀 겐티세이트 염과 이의 제조방법
|
US7262318B2
(en)
*
|
2004-03-10 |
2007-08-28 |
Pfizer, Inc. |
Substituted heteroaryl- and phenylsulfamoyl compounds
|
US20060030602A1
(en)
*
|
2004-03-16 |
2006-02-09 |
Sepracor Inc. |
(S)-amlodipine malate
|
US7244765B2
(en)
*
|
2004-06-25 |
2007-07-17 |
Cytokine Pharmasciences, Inc |
Guanylhydrazone salts, compositions, processes of making and methods of using
|
US20050288340A1
(en)
*
|
2004-06-29 |
2005-12-29 |
Pfizer Inc |
Substituted heteroaryl- and phenylsulfamoyl compounds
|
WO2006003672A1
(en)
*
|
2004-07-02 |
2006-01-12 |
Matrix Laboratories Ltd |
Process for the preparation of pure amlodipine
|
RU2007106714A
(ru)
*
|
2004-07-26 |
2008-09-10 |
Байер Шеринг Фарма Аг (De) |
Лечение легочной гипертензии путем ингаляции илопростата с препаратом микрочастиц
|
KR20070085801A
(ko)
*
|
2004-11-05 |
2007-08-27 |
베링거 인겔하임 인터내셔날 게엠베하 |
텔미사르탄 및 암로디핀을 포함하는 2층 정제
|
WO2006056845A1
(en)
*
|
2004-11-23 |
2006-06-01 |
Warner-Lambert Company Llc |
7-(2h-pyrazol-3-yl)-3, 5-dihyroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia
|
US20080305158A1
(en)
*
|
2004-12-28 |
2008-12-11 |
Ranbaxy Laboratories Limited |
Methods For the Preparation of Stable Pharmaceutical Solid Dosage Forms of Atorvastatin and Amlodipine
|
WO2006085208A2
(en)
*
|
2005-02-11 |
2006-08-17 |
Ranbaxy Laboratories Limited |
Stable solid dosage forms of amlodipine and benazepril
|
CA2613417C
(en)
*
|
2005-06-27 |
2011-11-29 |
Daiichi Sankyo Company, Limited |
Pharmaceutical preparation containing an angiotensin ii receptor antagonist and a calcium channel blocker
|
CA2613875C
(en)
|
2005-07-04 |
2018-09-25 |
Ramu Krishnan |
Improved drug or pharmaceutical compounds and a preparation thereof
|
ES2265781B1
(es)
*
|
2005-08-04 |
2007-12-01 |
Ercros Industrial, S.A. |
Procedimiento para la obtencion de besilato de amlodipina.
|
US7741317B2
(en)
|
2005-10-21 |
2010-06-22 |
Bristol-Myers Squibb Company |
LXR modulators
|
EP2351569B1
(en)
|
2005-10-26 |
2012-08-22 |
Asahi Kasei Pharma Corporation |
Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
|
US7893050B2
(en)
*
|
2005-10-26 |
2011-02-22 |
Asahi Kasei Pharma Corporation |
Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
|
CA2627599A1
(en)
*
|
2005-11-08 |
2007-05-18 |
Ranbaxy Laboratories Limited |
Process for (3r,5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino)carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt
|
US7888376B2
(en)
|
2005-11-23 |
2011-02-15 |
Bristol-Myers Squibb Company |
Heterocyclic CETP inhibitors
|
TW200806648A
(en)
*
|
2005-11-29 |
2008-02-01 |
Sankyo Co |
Acid addition salts of dihydropyridine derivatives
|
TW200736245A
(en)
*
|
2005-11-29 |
2007-10-01 |
Sankyo Co |
Acid addition salts of optically active dihydropyridine derivatives
|
US7919506B2
(en)
|
2006-03-10 |
2011-04-05 |
Pfizer Inc. |
Dibenzyl amine compounds and derivatives
|
TW200744583A
(en)
*
|
2006-03-14 |
2007-12-16 |
Ranbaxy Lab Ltd |
Statin stabilizing dosage formulations
|
US20070260065A1
(en)
*
|
2006-05-03 |
2007-11-08 |
Vijayabhaskar Bolugoddu |
Process for preparing amlodipine
|
CN101494980A
(zh)
*
|
2006-07-14 |
2009-07-29 |
兰贝克赛实验室有限公司 |
HMG-CoA还原酶抑制剂的多晶型形式及其应用
|
WO2008023869A1
(en)
*
|
2006-08-24 |
2008-02-28 |
Hanall Pharmaceutical Co., Ltd. |
Combined pharmeceutical formulation with controlled-release comprising dihydropyridine calcium channel blockers and hmg-coa reductase inhibitors
|
TWI399223B
(zh)
|
2006-09-15 |
2013-06-21 |
Daiichi Sankyo Co Ltd |
奧美沙坦酯及氨氯地平之固體劑型
|
US20080096863A1
(en)
*
|
2006-10-19 |
2008-04-24 |
Torrent Pharmaceuticals Limited |
Stable pharmaceutical compositions of calcium channel blocker and an ACE inhibitor
|
CN101167724B
(zh)
*
|
2006-10-25 |
2012-08-22 |
北京华安佛医药研究中心有限公司 |
含有氨氯地平的药物组合物在制备治疗下尿路疾病药物中的用途
|
KR100830003B1
(ko)
|
2006-10-31 |
2008-05-15 |
씨제이제일제당 (주) |
결정성 s-(-)-암로디핀 아디핀산 염 무수물 및 이의 제조방법
|
GB0624087D0
(en)
*
|
2006-12-01 |
2007-01-10 |
Selamine Ltd |
Ramipril combination salt
|
US8404896B2
(en)
|
2006-12-01 |
2013-03-26 |
Bristol-Myers Squibb Company |
N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
|
GB0624084D0
(en)
*
|
2006-12-01 |
2007-01-10 |
Selamine Ltd |
Ramipril amino acid salts
|
GB0624090D0
(en)
*
|
2006-12-01 |
2007-01-10 |
Selamine Ltd |
Ramipril amine salts
|
TWI384986B
(zh)
*
|
2007-01-17 |
2013-02-11 |
Lg Life Sciences Ltd |
抗病毒劑之順丁烯二酸單鹽以及含有該單鹽之醫藥組成物
|
CN101230035B
(zh)
*
|
2007-03-23 |
2010-11-03 |
浙江尖峰药业有限公司 |
门冬氨酸氨氯地平系列盐及其制备方法和其组合物、制剂以及片剂
|
EP1975167A1
(en)
*
|
2007-03-30 |
2008-10-01 |
Esteve Quimica, S.A. |
Acetone solvate of phthaloyl amlodipine
|
US20080249141A1
(en)
*
|
2007-04-06 |
2008-10-09 |
Palepu Nageswara R |
Co-therapy with and combinations of statins and 1,4-dihydropyridine-3,5-dicarboxydiesters
|
US20090062352A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched amlodipine
|
US8748648B2
(en)
*
|
2007-09-06 |
2014-06-10 |
Nektar Therapeutics |
Oligomer-calcium channel blocker conjugates
|
UY31531A1
(es)
*
|
2007-12-17 |
2009-08-03 |
|
Sales derivadas de 8-oxoadenina composiciones farmacéuticas que las contienen y su uso en terapia como moduladores de receptor tipo toll (tlr)
|
AU2008344891A1
(en)
*
|
2007-12-31 |
2009-07-09 |
Lupin Limited |
Pharmaceutical compositions of amlodipine and valsartan
|
EP2253318B1
(en)
|
2008-03-13 |
2014-08-06 |
Daiichi Sankyo Company, Limited |
Improvement of dissolvability of preparation containing olmesartan medoxomil
|
CN101560181B
(zh)
*
|
2008-04-16 |
2013-02-27 |
北京万全阳光医学技术有限公司 |
一种氨氯地平游离碱的制备方法
|
CN101367759B
(zh)
*
|
2008-10-06 |
2011-03-16 |
北京赛科药业有限责任公司 |
一种高纯度苯磺酸氨氯地平的合成方法
|
JP2010100562A
(ja)
*
|
2008-10-23 |
2010-05-06 |
Daito Kk |
アムロジピン製造中間体の精製方法
|
WO2010139111A1
(en)
|
2009-06-02 |
2010-12-09 |
Dow Global Technologies Inc. |
Sustained release dosage form
|
CA2783699C
(en)
|
2009-12-08 |
2019-01-15 |
Case Western Reserve University |
Primary amine compounds for treating ocular disorders
|
WO2011117876A1
(en)
|
2010-03-26 |
2011-09-29 |
Fdc Limited |
An improved process for the preparation of amlodipine free base and acid addition salts thereof
|
IT1400309B1
(it)
*
|
2010-05-10 |
2013-05-24 |
Menarini Int Operations Lu Sa |
Associazione di inibitori della xantina ossidasi e calcio antagonisti e loro uso.
|
WO2011149438A1
(en)
|
2010-05-28 |
2011-12-01 |
Mahmut Bilgic |
Combination of antihypertensive agents
|
EP2575757A1
(en)
|
2010-06-03 |
2013-04-10 |
Mahmut Bilgic |
Water soluble formulation comprising a combination of amlodipine and a statin
|
US8883844B2
(en)
|
2010-09-24 |
2014-11-11 |
Nitrogenix Inc. |
Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
|
WO2012055941A1
(en)
|
2010-10-27 |
2012-05-03 |
Krka,Tovarna Zdravil, D. D., Novo Mesto |
Multilayer pharmaceutical composition comprising telmisartan and amlodipine
|
TR201100152A2
(tr)
|
2011-01-06 |
2012-07-23 |
Bi̇lgi̇ç Mahmut |
Amlodipin içeren efervesan bileşimler.
|
CN102070516A
(zh)
*
|
2011-02-22 |
2011-05-25 |
广东东阳光药业有限公司 |
一种制备氨氯地平的方法
|
WO2012123966A1
(en)
|
2011-03-04 |
2012-09-20 |
Arch Pharmalabs Limited |
Process for the preparation of 4 -substituted -1, 4-dihydropyridines
|
AU2011365756B2
(en)
|
2011-04-12 |
2015-07-30 |
Boryung Pharmaceutical Co., Ltd. |
Antihypertensive pharmaceutical composition
|
CA2846387C
(en)
|
2011-08-26 |
2016-02-09 |
Wockhardt Limited |
Methods for treating cardiovascular disorders
|
CN102382041B
(zh)
*
|
2011-12-02 |
2016-01-20 |
东北制药集团股份有限公司 |
一种马来酸氨氯地平的制备方法
|
PL236001B1
(pl)
|
2012-12-21 |
2020-11-30 |
Adamed Spolka Z Ograniczona Odpowiedzialnoscia |
Złożona kompozycja farmaceutyczna zawierająca kandesartan cyleksetylu oraz amlodypinę, sposób jej wytwarzania oraz jednostkowa postać dawkowania zawierająca tę kompozycję
|
CN103044314A
(zh)
*
|
2013-01-06 |
2013-04-17 |
先声药业有限公司 |
马来酸氨氯地平的制备方法
|
JP5952748B2
(ja)
*
|
2013-01-25 |
2016-07-13 |
東和薬品株式会社 |
フタロイルアムロジピンの新規結晶形態およびそれを用いる高純度なアムロジピンベシル酸塩の製造方法
|
WO2014122585A1
(en)
|
2013-02-08 |
2014-08-14 |
Wockhardt Limited |
A stable pharmaceutical composition of amlodipine and benazepril or salts thereof
|
AU2014255381A1
(en)
|
2013-04-17 |
2015-10-08 |
Pfizer Inc. |
N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
|
WO2015012205A1
(ja)
|
2013-07-23 |
2015-01-29 |
第一三共株式会社 |
高血圧症の予防又は治療のための医薬
|
CN104262237A
(zh)
*
|
2014-09-28 |
2015-01-07 |
常州瑞明药业有限公司 |
氨氯地平自由碱的合成方法
|
WO2016055901A1
(en)
|
2014-10-08 |
2016-04-14 |
Pfizer Inc. |
Substituted amide compounds
|
CN104529877A
(zh)
*
|
2015-01-22 |
2015-04-22 |
华东理工常熟研究院有限公司 |
氨氯地平-癸酸离子液体及其制备方法和用途
|
CZ2015687A3
(cs)
|
2015-10-02 |
2017-04-12 |
Zentiva, K.S. |
Farmaceutická kompozice obsahující kombinaci kandesartanu, amlodipinu a hydrochlorthiazidu
|
WO2017068532A1
(en)
|
2015-10-23 |
2017-04-27 |
Ftf Pharma Private Limited |
Oral solution of dihydropyridine derivatives
|
EP3434284A4
(en)
|
2016-03-24 |
2019-11-13 |
Daiichi Sankyo Company, Limited |
MEDICINE FOR THE TREATMENT OF KIDNEY DISEASE
|
EP3463309B1
(en)
|
2016-05-30 |
2020-06-17 |
Boehringer Ingelheim International GmbH |
Fixed dose combination of telmisartan, hydrochlorothiazide and amlodipine
|
EP3960158A1
(en)
|
2016-10-07 |
2022-03-02 |
Silvergate Pharmaceuticals, Inc. |
Amlodipine formulations
|
US10350171B2
(en)
|
2017-07-06 |
2019-07-16 |
Dexcel Ltd. |
Celecoxib and amlodipine formulation and method of making the same
|
JP7456933B2
(ja)
|
2018-04-11 |
2024-03-27 |
シルバーゲイト ファーマシューティカルズ,インク. |
アムロジピン製剤
|
EP3807889A1
(en)
|
2018-06-14 |
2021-04-21 |
AstraZeneca UK Limited |
Methods for treating and preventing symptoms of asthma with a corticosteroid pharmaceutical composition
|
CA3103616A1
(en)
|
2018-06-14 |
2019-12-19 |
Astrazeneca Uk Limited |
Methods for lowering blood pressure with a dihydropyridine-type calcium channel blocker pharmaceutical composition
|
US11248001B2
(en)
|
2019-01-18 |
2022-02-15 |
Astrazeneca Ab |
PCSK9 inhibitors and methods of use thereof
|
EP3972421A1
(en)
|
2019-05-21 |
2022-03-30 |
Société des Produits Nestlé S.A. |
Dietary butyrate
|
GB2595203A
(en)
|
2020-03-03 |
2021-11-24 |
Alkaloid Ad Skopje |
Formulation
|
GB202102575D0
(en)
|
2021-02-23 |
2021-04-07 |
Teva Pharmaceutical Industries Ltd |
Fixed-dose pharmaceutical compositions
|